keyword
https://read.qxmd.com/read/38605928/targeted-therapeutic-options-in-early-and-metastatic-nsclc-overview
#21
REVIEW
Gabriella Gálffy, Éva Morócz, Réka Korompay, Réka Hécz, Réka Bujdosó, Rita Puskás, Tímea Lovas, Eszter Gáspár, Kamel Yahya, Péter Király, Zoltán Lohinai
The complex therapeutic strategy of non-small cell lung cancer (NSCLC) has changed significantly in recent years. Disease-free survival increased significantly with immunotherapy and chemotherapy registered in perioperative treatments, as well as adjuvant registered immunotherapy and targeted therapy (osimertinib) in case of EGFR mutation. In oncogenic-addictive metastatic NSCLC, primarily in adenocarcinoma, the range of targeted therapies is expanding, with which the expected overall survival increases significantly, measured in years...
2024: Pathology Oncology Research: POR
https://read.qxmd.com/read/38605591/cone-beam-computed-tomography-assessment-of-maxillary-anterior-teeth-cervix-dimensions-in-healthy-adults-for-optimal-anatomic-healing-abutments
#22
JOURNAL ARTICLE
Jie Lu, Yanjing Ou, Wei Zhao, Huachen Chen, Kaixun He, Hanyu Lin, Jiang Chen
OBJECTIVES: The abutments produced with circular symmetry failed to accurately replicate the natural teeth's cervical shapes. The purpose of this study was to measure cervical cross-sections of maxillary anterior teeth using cone beam computed tomography (CBCT) images to design anatomic healing abutments. MATERIALS AND METHODS: CBCT data of 61 patients were analyzed using Ez3D Plus software. Measurements were taken at the cemento-enamel junction (CEJ) and 1 mm coronal to CEJ for maxillary central incisors, lateral incisors, and canines...
April 11, 2024: Journal of Esthetic and Restorative Dentistry
https://read.qxmd.com/read/38605477/nuclear-autoantigenic-sperm-protein-facilitates-glioblastoma-progression-and-radioresistance-by-regulating-the-anxa2-stat3-axis
#23
JOURNAL ARTICLE
Yuning Qiu, Dongling Pei, Minkai Wang, Qimeng Wang, Wenchao Duan, Li Wang, Kehan Liu, Yu Guo, Lin Luo, Zhixuan Guo, Fangzhan Guan, Zilong Wang, Aoqi Xing, Zhongyi Liu, Zeyu Ma, Guozhong Jiang, Dongming Yan, Xianzhi Liu, Zhenyu Zhang, Weiwei Wang
AIMS: Although radiotherapy is a core treatment modality for various human cancers, including glioblastoma multiforme (GBM), its clinical effects are often limited by radioresistance. The specific molecular mechanisms underlying radioresistance are largely unknown, and the reduction of radioresistance is an unresolved challenge in GBM research. METHODS: We analyzed and verified the expression of nuclear autoantigenic sperm protein (NASP) in gliomas and its relationship with patient prognosis...
April 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38605404/delineating-morbidity-patterns-in-preterm-infants-at-near-term-age-using-a-data-driven-approach
#24
JOURNAL ARTICLE
Octavia-Andreea Ciora, Tanja Seegmüller, Johannes S Fischer, Theresa Wirth, Friederike Häfner, Sophia Stoecklein, Andreas W Flemmer, Kai Förster, Alida Kindt, Dirk Bassler, Christian F Poets, Narges Ahmidi, Anne Hilgendorff
BACKGROUND: Long-term survival after premature birth is significantly determined by development of morbidities, primarily affecting the cardio-respiratory or central nervous system. Existing studies are limited to pairwise morbidity associations, thereby lacking a holistic understanding of morbidity co-occurrence and respective risk profiles. METHODS: Our study, for the first time, aimed at delineating and characterizing morbidity profiles at near-term age and investigated the most prevalent morbidities in preterm infants: bronchopulmonary dysplasia (BPD), pulmonary hypertension (PH), mild cardiac defects, perinatal brain pathology and retinopathy of prematurity (ROP)...
April 11, 2024: BMC Pediatrics
https://read.qxmd.com/read/38604814/oma1-competitively-binds-to-hspa9-to-promote-mitophagy-and-activate-the-cgas-sting-pathway-to-mediate-gbm-immune-escape
#25
JOURNAL ARTICLE
Wen de Zhu, Jin Rao, Li Hua Zhang, Ka Ming Xue, Lin Li, Jun Jun Li, Qian Zhi Chen, Rong Fu
BACKGROUND: Immunotherapy with checkpoint inhibitors, especially those targeting programmed death receptor 1 (PD-1)/PD-1 ligand (PD-L1), is increasingly recognized as a highly promising therapeutic modality for malignancies. Nevertheless, the efficiency of immune checkpoint blockade therapy in treating glioblastoma (GBM) is constrained. Hence, it is imperative to expand our comprehension of the molecular mechanisms behind GBM immune escape (IE). METHODS: Protein chip analysis was performed to screen aberrantly expressed OMA1 protein in PD-1 inhibitor sensitive or resistant GBM...
April 11, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38604320/management-of-depth-to-achieve-timely-arterio-venous-fistula-utilization
#26
JOURNAL ARTICLE
Tracy J Cheun, Joseph P Hart, Mark G Davies
BACKGROUND: Failure to achieve timely arteriovenous fistulae (AVF) utilization due to excessive depth (>6mm) remains an ongoing concern for dialysis access. This study evaluates the outcomes of radio cephalic (RCF) and brachiocephalic (BCF) fistula elevation required for access utilization. METHODS: A retrospective review of all patients undergoing first-time autologous access over 10 years was undertaken. RCF and BCF were analyzed, and cases of initial access failure due to depth alone were selected for study...
April 9, 2024: Journal of Vascular Surgery
https://read.qxmd.com/read/38604270/intestinal-madcam-1-imaging-as-biomarker-for-prognostic-in-murine-models-of-multiple-sclerosis
#27
JOURNAL ARTICLE
Erwan Baudron, Sara Martinez de Lizarrondo, Maxime Gauberti, Barbara Delaunay-Piednoir, Antoine P Fournier, Denis Vivien, Fabian Docagne, Isabelle Bardou
INTRODUCTION: Multiple sclerosis (MS) is an autoimmune disease of the central nervous system. Recent evidence suggests that lymphocyte trafficking in the intestines could play a key role in its etiology. Nevertheless, it is not clear how intestinal tissue is involved in the disease onset nor its evolution. In the present study, we aimed to evaluate intestinal inflammation dynamic throughout the disease course and its potential impact on disease progression. METHODS: We used tissue immunophenotyping (immunohistofluorescence and flow cytometry) and a recently described molecular magnetic resonance imaging (MRI) method targeting mucosal addressin cell adhesion molecule-1 (MAdCAM-1) to assess intestinal inflammation in vivo in two distinct animal models of MS (Experimental Autoimmune Encephalomyelitis - EAE) at several time points of disease progression...
April 9, 2024: Brain, Behavior, and Immunity
https://read.qxmd.com/read/38603651/phase-ii-study-of-erdafitinib-in-patients-with-tumors-with-fgfr-amplifications-results-from-the-nci-match-ecog-acrin-trial-eay131-subprotocol-k1
#28
JOURNAL ARTICLE
Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Ajjai S Alva, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
PURPOSE: Despite fibroblast growth factor receptor ( FGFR ) inhibitors being approved in tumor types with select FGFR rearrangements or gene mutations, amplifications of FGFR represent the most common FGFR alteration across malignancies. Subprotocol K1 (EAY131-K1) of the National Cancer Institute-MATCH platform trial was designed to evaluate the antitumor efficacy of the oral FGFR1-4 inhibitor, erdafitinib, in patients with tumors harboring FGFR1-4 amplification. METHODS: EAY131-K1 was an open-label, single-arm, phase II study with central confirmation of presence of FGFR1-4 amplification in tumors...
April 2024: JCO Precision Oncology
https://read.qxmd.com/read/38603650/phase-ii-study-of-erdafitinib-in-patients-with-tumors-with-fibroblast-growth-factor-receptor-mutations-or-fusions-results-from-the-nci-match-ecog-acrin-trial-eay131-subprotocol-k2
#29
JOURNAL ARTICLE
Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
PURPOSE: Subprotocol K2 (EAY131-K2) of the NCI-MATCH platform trial was an open-label, single-arm, phase II study designed to evaluate the antitumor efficacy of the oral FGFR1-4 inhibitor, erdafitinib, in patients with tumors harboring FGFR1-4 mutations or fusions. METHODS: Central confirmation of tumor FGFR1-4 mutations or fusions was required for outcome analysis. Patients with urothelial carcinoma were excluded. Enrolled subjects received oral erdafitinib at a starting dose of 8 mg daily continuously until intolerable toxicity or disease progression...
April 2024: JCO Precision Oncology
https://read.qxmd.com/read/38601487/efficacy-and-safety-of-first-line-treatment-for-metastatic-triple-negative-breast-cancer-a-network-meta-analysis
#30
REVIEW
Mingqiang Shi, Zhoujuan Li, Guoshuang Shen, Tianzhuo Wang, Jinming Li, Miaozhou Wang, Zhen Liu, Fuxing Zhao, Dengfeng Ren, Jiuda Zhao
BACKGROUND: Metastatic triple-negative breast cancer (mTNBC) is an aggressive histological subtype with poor prognosis. Several first-line treatments are currently available for mTNBC. This study conducted a network meta-analysis to compare these first-line regimens and to determine the regimen with the best efficacy. METHODS: A systematic search of PubMed, EMBASE, the Cochrane Central Register of Controlled Bases, and minutes of major conferences was performed...
April 2024: Cancer Pathog Ther
https://read.qxmd.com/read/38601152/the-effects-of-pediococcus-acidilactici-ma18-5m-on-growth-performance-gut-integrity-and-immune-response-using-in-vitro-and-in-vivo-pacific-salmonid-models
#31
JOURNAL ARTICLE
Manuel Soto-Dávila, Luana Langlois Fiorotto, John W Heath, John S Lumsden, Gregor Reid, Brian Dixon
Microbial management is central to aquaculture's efficiency. Pediococcus acidilactici MA18/5M has shown promising results promoting growth, modulation of the immune response, and disease resistance in many fishes. However, the mechanisms through which this strain confers health benefits in fish are poorly understood, particularly in Pacific salmonid models. Briefly, the aims of this study were to i) assess the protective effects of P. acidilactici MA18/5M by examining gut barrier function and the expression of tight junction (TJ) and immune genes in vitro and in vivo , and ii) to determine the protective effects of this strain against a common saltwater pathogen, Vibrio anguillarum J382...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38601063/managing-catecholamine-release-syndrome-during-and-following-lu-177-dotatate-in-high-risk-pheochromocytoma-patients
#32
Tim E Phelps, Jaydira Del Rivero, Daniel S Chertow, Douglas Rosing, Karel Pacak, Frank I Lin
Pheochromocytomas and paragangliomas (PPGLs) are rare catecholamine-producing tumors that express somatostatin receptors (SSTR) that can be treated with lutetium-177 DOTATATE (Lu-177-TRT); however, treatment can be associated with life-threatening cardiovascular events. A patient case with management strategies for high-risk PPGL patients receiving Lu-177-TRT is described. The 78-year-old patient with metastatic paraganglioma was enrolled and treated under NCT03206060. Deemed to be at high risk, the patient was preemptively admitted to the intensive care unit (ICU) with central line access placed...
April 2024: JCEM Case Rep
https://read.qxmd.com/read/38600611/validating-the-anatomical-landmark-technique-for-bedside-tunneled-central-venous-catheter-placement-in-the-medical-intensive-care-unit
#33
JOURNAL ARTICLE
Hanny Sawaf, James Lane, Roman Shingarev, Matthew Siuba, Alvin G Kwon, Tarik Hanane, Tushar J Vachharajani
BACKGROUND: A non-tunneled dialysis catheter (nTDC) is often the vascular access of choice to initiate dialysis in an intensive care unit (ICU). In the absence of contraindications, if a patient remains dialysis dependent beyond 2-weeks, the options are either to replace the nTDC with another nTDC or convert to a tunneled dialysis catheter (TDC). As a standard of care, TDCs are placed under fluoroscopic guidance. OBJECTIVES: To determine if TDCs and other tunneled central venous catheters (tCVC) can be placed safely using anatomical landmark techniques without the use of fluoroscopy...
April 10, 2024: Journal of Vascular Access
https://read.qxmd.com/read/38600526/surveillance-of-catheter-associated-bloodstream-infections-development-and-validation-of-a-fully-automated-algorithm
#34
JOURNAL ARTICLE
Gaud Catho, Loïc Fortchantre, Daniel Teixeira, Murielle Galas-Haddad, Filippo Boroli, Marie-Noëlle Chraïti, Mohamed Abbas, Stephan Harbarth, Niccolò Buetti
BACKGROUND: Most surveillance systems for catheter-related bloodstream infections (CRBSI) and central line-associated bloodstream infections (CLABSI) are based on manual chart review. Our objective was to validate a fully automated algorithm for CRBSI and CLABSI surveillance in intensive care units (ICU). METHODS: We developed a fully automated algorithm to detect CRBSI, CLABSI and ICU-onset bloodstream infections (ICU-BSI) in patients admitted to the ICU of a tertiary care hospital in Switzerland...
April 10, 2024: Antimicrobial Resistance and Infection Control
https://read.qxmd.com/read/38600340/eclim-sehop-how-to-develop-a-platform-to-conduct-academic-trials-for-childhood-cancer
#35
JOURNAL ARTICLE
Antonio Juan-Ribelles, Francisco Bautista, Adela Cañete, Alba Rubio-San-Simón, Anna Alonso-Saladrigues, Raquel Hladun, Susana Rives, Jose Luís Dapena, Jose María Fernández, Álvaro Lassaletta, Ofelia Cruz, Gemma Ramírez-Villar, Jose Luís Fuster, Cristina Diaz de Heredia, Miguel García-Ariza, Eduardo Quiroga, María Del Mar Andrés, Jaime Verdú-Amorós, Antonio Molinés, Blanca Herrero, Mónica López, Catalina Márquez, María Toboso, Frencisco Lendínez, Jose Gómez Sirvent, María Tallón, Guiomar Rodríguez, Tomás Acha, Lucas Moreno, Ana Fernández-Teijeiro
INTRODUCTION: ECLIM-SEHOP platform was created in 2017. Its main objective is to establish the infrastructure to allow Spanish participation into international academic collaborative clinical trials, observational studies, and registries in pediatric oncology. The aim of this manuscript is to describe the activity conducted by ECLIM-SEHOP since its creation. METHODS: The platform's database was queried to provide an overview of the studies integrally and partially supported by the organization...
April 10, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/38597202/bruton-s-tyrosine-kinase-btk-inhibitors-for-the-treatment-of-primary-central-nervous-system-lymphoma-pcnsl-current-progress-and-latest-advances
#36
REVIEW
Lauren Schaff, Lakshmi Nayak, Christian Grommes
The incidence of primary central nervous system lymphoma (PCNSL) has steadily increased, particularly in elderly patients. Although highly responsive to first-line chemotherapy and radiotherapy, approximately 50% of patients relapse or become refractory within 1 year. Prognosis following relapse is dismal and no standard salvage therapy exists. Bruton's tyrosine kinase (BTK), a key regulator of the B-cell receptor (BCR) pathway, has emerged as a promising therapeutic target. The first BTK inhibitor ibrutinib has been evaluated in the relapsed/refractory PCNSL setting, with overall response rates of 51...
April 10, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38597112/orphan-gpcr-gprc5c-facilitates-angiotensin-ii-induced-smooth-muscle-contraction
#37
JOURNAL ARTICLE
Tianpeng Wang, Jingchen Shao, Shamit Kumar, Mohammad Wessam Alnouri, Jorge Carvalho, Stefan Günther, Cornelius Krasel, Kate T Murphy, Moritz Bünemann, Stefan Offermanns, Nina Wettschureck
BACKGROUND: GPCRs (G-protein-coupled receptors) play a central role in the regulation of smooth muscle cell (SMC) contractility, but the function of SMC-expressed orphan GPCR class C group 5 member C (GPRC5C) is unclear. OBJECTIVE: The aim of this project is to define the role of GPRC5C in SMC in vitro and in vivo. METHODS AND RESULTS: We studied the role of GPRC5C in the regulation of SMC contractility and differentiation in human and murine SMC in vitro, as well as in tamoxifen-inducible, SMC-specific GPRC5C knockout mice under basal conditions and in vascular disease in vivo...
April 10, 2024: Circulation Research
https://read.qxmd.com/read/38596030/biomimetic-nanocarriers-loaded-with-temozolomide-by-cloaking-brain-targeting-peptides-for-targeting-drug-delivery-system-to-promote-anticancer-effects-in-glioblastoma-cells
#38
JOURNAL ARTICLE
Huaming Chen, Yunhong Wang, Hai Wang, Kun Zhang, Yunfei Liu, Qiangfeng Li, Chengli Li, Zhonghui Wen, Ziyu Chen
Glioma is the leading cancer of the central nervous system (CNS). The efficacy of glioma treatment is significantly hindered by the presence of the blood-brain barrier (BBB) and blood-brain tumour barrier (BBTB), which prevent most drugs from entering the brain and tumours. Hence, we established a novel drug delivery nanosystem of brain tumour-targeting that could self-assemble the method using an amphiphilic Zein protein isolated from corn. Zein's amphiphilicity prompted it to self-assembled into NPs, efficiently containing TMZ...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38595149/central-neuromodulators-in-irritable-bowel-syndrome-why-how-and-when
#39
JOURNAL ARTICLE
Ignacio Hanna-Jairala, Douglas A Drossman
Irritable bowel syndrome are responsive to treatments using central neuromodulators. Central neuromodulators work by enhancing the synaptic transmission of 5-hydroxytryptamine, noradrenalin and dopamine, achieving a slower regulation or desensitization of their postsynaptic receptors. Central neuromodulators act on receptors along the brain-gut axis, so they are useful in treating psychiatric comorbidities, modifying gut motility, improving central downregulation of visceral signals and enhancing neurogenesis in patients with IBS...
April 9, 2024: American Journal of Gastroenterology
https://read.qxmd.com/read/38594388/conversion-of-astrocyte-cell-lines-to-oligodendrocyte-progenitor-cells-using-small-molecules-and-transplantation-to-animal-model-of-multiple-sclerosis
#40
JOURNAL ARTICLE
Mohsen Sharifi-Kelishadi, Leila Zare, Yaghoub Fathollahi, Mohammad Javan
Astrocytes, the most prevalent cells in the central nervous system (CNS), can be transformed into neurons and oligodendrocyte progenitor cells (OPCs) using specific transcription factors and some chemicals. In this study, we present a cocktail of small molecules that target different signaling pathways to promote astrocyte conversion to OPCs. Astrocytes were transferred to an OPC medium and exposed for five days to a small molecule cocktail containing CHIR99021, Forskolin, Repsox, LDN, VPA and Thiazovivin before being preserved in the OPC medium for an additional 10 days...
April 9, 2024: Journal of Molecular Neuroscience: MN
keyword
keyword
19766
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.